Literature DB >> 15870077

Jumonji regulates cardiomyocyte proliferation via interaction with retinoblastoma protein.

Jooyoung Jung1, Tae-Gyun Kim, Gary E Lyons, Hyeong-Reh C Kim, Youngsook Lee.   

Abstract

Jumonji (JMJ) can function as a transcriptional repressor and plays critical roles in embryonic development including heart development in mice. Although JMJ has been suggested to play a role in cell growth, the molecular mechanisms have not been resolved. The present data demonstrate that JMJ interacts with the retinoblastoma protein (Rb), one of the master regulatory genes of cell cycle. JMJ potentiates the repression function of Rb on E2F activities, leading to reduced cell cycle progression. The transcriptional repression domain of JMJ is critical for the interaction with Rb as well as repression of cell cycle. The physiological relevance of the association between Rb and JMJ was assessed in cardiomyocytes. Primary cardiomyocytes cultured from homozygous jmj knock-out mouse embryos (jmj mutants) show increased cell mitosis in a cardiomyocyte-specific manner. Reporter gene analyses demonstrate that promoter activities of cyclin D1, cyclin D2, and Cdc2 are up-regulated in jmj mutant cardiomyocytes. These data suggest that JMJ down-regulates the cell growth via interaction with Rb, which would provide important insights into the cardiac defects observed in jmj mutant mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870077     DOI: 10.1074/jbc.M414482200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  The JARID2-PRC2 duality.

Authors:  Hans-Martin Herz; Ali Shilatifard
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

Review 2.  Cardiac myocyte cell cycle control in development, disease, and regeneration.

Authors:  Preeti Ahuja; Patima Sdek; W Robb MacLellan
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 3.  Embryonic stem cell-specific signature in cervical cancer.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Patricio Gariglio
Journal:  Tumour Biol       Date:  2013-10-28

Review 4.  Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

Authors:  Paul A C Cloos; Jesper Christensen; Karl Agger; Kristian Helin
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

5.  Jarid2 and PRC2, partners in regulating gene expression.

Authors:  Gang Li; Raphael Margueron; Manching Ku; Pierre Chambon; Bradley E Bernstein; Danny Reinberg
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

6.  Jarid2 regulates mouse epidermal stem cell activation and differentiation.

Authors:  Stefania Mejetta; Lluis Morey; Gloria Pascual; Bernd Kuebler; Matthew R Mysliwiec; Youngsook Lee; Ramin Shiekhattar; Luciano Di Croce; Salvador Aznar Benitah
Journal:  EMBO J       Date:  2011-08-02       Impact factor: 11.598

7.  Jarid2 (Jumonji, AT rich interactive domain 2) regulates NOTCH1 expression via histone modification in the developing heart.

Authors:  Matthew R Mysliwiec; Clayton D Carlson; Josh Tietjen; Holly Hung; Aseem Z Ansari; Youngsook Lee
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

8.  14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle.

Authors:  Yasuhiro Kosaka; Katarzyna A Cieslik; Ling Li; George Lezin; Colin T Maguire; Yukio Saijoh; Kazuhito Toyo-oka; Michael J Gambello; Matteo Vatta; Anthony Wynshaw-Boris; Antonio Baldini; H Joseph Yost; Luca Brunelli
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

9.  Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine.

Authors:  Arun Sharma; Yuan Zhang; Sean M Wu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-10

10.  Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival.

Authors:  Mohan T Bolisetty; George Dy; Wayne Tam; Karen L Beemon
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.